Cargando…

Incidence of headache after COVID-19 vaccination in patients with history of headache: A cross-sectional study

BACKGROUND: Headache is an adverse event of coronavirus 2019 (COVID-19) vaccination. Whether patients with history of headache suffer more from vaccination-induced headaches is unknown. We aimed to uncover if headache patients develop more headaches after COVID-19 mRNA vaccination than healthy contr...

Descripción completa

Detalles Bibliográficos
Autores principales: Sekiguchi, Koji, Watanabe, Narumi, Miyazaki, Naoki, Ishizuchi, Kei, Iba, Chisato, Tagashira, Yu, Uno, Shunsuke, Shibata, Mamoru, Hasegawa, Naoki, Takemura, Ryo, Nakahara, Jin, Takizawa, Tsubasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988452/
https://www.ncbi.nlm.nih.gov/pubmed/34407651
http://dx.doi.org/10.1177/03331024211038654
_version_ 1784682963555844096
author Sekiguchi, Koji
Watanabe, Narumi
Miyazaki, Naoki
Ishizuchi, Kei
Iba, Chisato
Tagashira, Yu
Uno, Shunsuke
Shibata, Mamoru
Hasegawa, Naoki
Takemura, Ryo
Nakahara, Jin
Takizawa, Tsubasa
author_facet Sekiguchi, Koji
Watanabe, Narumi
Miyazaki, Naoki
Ishizuchi, Kei
Iba, Chisato
Tagashira, Yu
Uno, Shunsuke
Shibata, Mamoru
Hasegawa, Naoki
Takemura, Ryo
Nakahara, Jin
Takizawa, Tsubasa
author_sort Sekiguchi, Koji
collection PubMed
description BACKGROUND: Headache is an adverse event of coronavirus 2019 (COVID-19) vaccination. Whether patients with history of headache suffer more from vaccination-induced headaches is unknown. We aimed to uncover if headache patients develop more headaches after COVID-19 mRNA vaccination than healthy controls. METHODS: We performed a questionnaire survey for nursing staff in our hospital from April to May 2021. Based on baseline characteristics, we divided the participants into migraine, non-migrainous headache, and healthy control, and examined the occurrence and features of headache after COVID-19 vaccinations. RESULTS: We included 171 participants (15.2% migraine and 24.6% non-migrainous headache). Headache incidence after vaccinations was significantly higher in the migraine (69.2%) and non-migrainous headache (71.4%) groups than in the healthy control (37.9%) group. The incidence of headaches was significantly higher after the second dose compared to the first (45.6% vs. 20.5%). CONCLUSION: Migraineurs and non-migrainous headache participants developed more headaches compared to the healthy controls after COVID-19 vaccination.
format Online
Article
Text
id pubmed-8988452
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-89884522022-04-08 Incidence of headache after COVID-19 vaccination in patients with history of headache: A cross-sectional study Sekiguchi, Koji Watanabe, Narumi Miyazaki, Naoki Ishizuchi, Kei Iba, Chisato Tagashira, Yu Uno, Shunsuke Shibata, Mamoru Hasegawa, Naoki Takemura, Ryo Nakahara, Jin Takizawa, Tsubasa Cephalalgia Brief Communications BACKGROUND: Headache is an adverse event of coronavirus 2019 (COVID-19) vaccination. Whether patients with history of headache suffer more from vaccination-induced headaches is unknown. We aimed to uncover if headache patients develop more headaches after COVID-19 mRNA vaccination than healthy controls. METHODS: We performed a questionnaire survey for nursing staff in our hospital from April to May 2021. Based on baseline characteristics, we divided the participants into migraine, non-migrainous headache, and healthy control, and examined the occurrence and features of headache after COVID-19 vaccinations. RESULTS: We included 171 participants (15.2% migraine and 24.6% non-migrainous headache). Headache incidence after vaccinations was significantly higher in the migraine (69.2%) and non-migrainous headache (71.4%) groups than in the healthy control (37.9%) group. The incidence of headaches was significantly higher after the second dose compared to the first (45.6% vs. 20.5%). CONCLUSION: Migraineurs and non-migrainous headache participants developed more headaches compared to the healthy controls after COVID-19 vaccination. SAGE Publications 2021-08-18 2022-03 /pmc/articles/PMC8988452/ /pubmed/34407651 http://dx.doi.org/10.1177/03331024211038654 Text en © International Headache Society 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Brief Communications
Sekiguchi, Koji
Watanabe, Narumi
Miyazaki, Naoki
Ishizuchi, Kei
Iba, Chisato
Tagashira, Yu
Uno, Shunsuke
Shibata, Mamoru
Hasegawa, Naoki
Takemura, Ryo
Nakahara, Jin
Takizawa, Tsubasa
Incidence of headache after COVID-19 vaccination in patients with history of headache: A cross-sectional study
title Incidence of headache after COVID-19 vaccination in patients with history of headache: A cross-sectional study
title_full Incidence of headache after COVID-19 vaccination in patients with history of headache: A cross-sectional study
title_fullStr Incidence of headache after COVID-19 vaccination in patients with history of headache: A cross-sectional study
title_full_unstemmed Incidence of headache after COVID-19 vaccination in patients with history of headache: A cross-sectional study
title_short Incidence of headache after COVID-19 vaccination in patients with history of headache: A cross-sectional study
title_sort incidence of headache after covid-19 vaccination in patients with history of headache: a cross-sectional study
topic Brief Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988452/
https://www.ncbi.nlm.nih.gov/pubmed/34407651
http://dx.doi.org/10.1177/03331024211038654
work_keys_str_mv AT sekiguchikoji incidenceofheadacheaftercovid19vaccinationinpatientswithhistoryofheadacheacrosssectionalstudy
AT watanabenarumi incidenceofheadacheaftercovid19vaccinationinpatientswithhistoryofheadacheacrosssectionalstudy
AT miyazakinaoki incidenceofheadacheaftercovid19vaccinationinpatientswithhistoryofheadacheacrosssectionalstudy
AT ishizuchikei incidenceofheadacheaftercovid19vaccinationinpatientswithhistoryofheadacheacrosssectionalstudy
AT ibachisato incidenceofheadacheaftercovid19vaccinationinpatientswithhistoryofheadacheacrosssectionalstudy
AT tagashirayu incidenceofheadacheaftercovid19vaccinationinpatientswithhistoryofheadacheacrosssectionalstudy
AT unoshunsuke incidenceofheadacheaftercovid19vaccinationinpatientswithhistoryofheadacheacrosssectionalstudy
AT shibatamamoru incidenceofheadacheaftercovid19vaccinationinpatientswithhistoryofheadacheacrosssectionalstudy
AT hasegawanaoki incidenceofheadacheaftercovid19vaccinationinpatientswithhistoryofheadacheacrosssectionalstudy
AT takemuraryo incidenceofheadacheaftercovid19vaccinationinpatientswithhistoryofheadacheacrosssectionalstudy
AT nakaharajin incidenceofheadacheaftercovid19vaccinationinpatientswithhistoryofheadacheacrosssectionalstudy
AT takizawatsubasa incidenceofheadacheaftercovid19vaccinationinpatientswithhistoryofheadacheacrosssectionalstudy